Curcumin

botanical

Curcumin is the main active polyphenol extracted from the rhizome of Curcuma longa, or turmeric. This yellow compound gives turmeric its color and many of its biological effects. It has been widely studied for its ability to reduce inflammation and oxidative stress at the cellular level. Its mechanisms involve modulating molecular targets including enzymes, transcription factors, and signaling pathways involved in inflammation and cellular defense. These effects make it a subject of research in areas such as joint comfort and cognitive function. Because curcumin typically has low bioavailability and is not easily absorbed, research focuses on enhancing its uptake. Formulations often include fats or other compounds to improve systemic availability so the body can better utilize its properties.

Natural sources
Turmeric (Curcuma longa)

Ingredient forms

No public comparison lists found.

Timing & Intake
AnytimeWith foodTake with Fats or oils to enhance absorption.
Taking curcumin with a meal containing fats significantly improves its absorption and bioavailability.
Optimal Dosage
Minimum500 mg
Maximum2000 mg
Safety & Toxicity
4 safety notes
  • Individuals with gallstones or bile duct obstruction should consult a healthcare professional before use, as curcumin can stimulate bile production.
  • May have mild blood-thinning effects; use with caution if you have a bleeding disorder or are scheduled for surgery.
  • Pregnant or breastfeeding individuals should consult a healthcare professional before use due to limited safety data.
  • May interact with certain medications; consult a healthcare professional if taking prescription drugs.
Goals
Cognitive Support
Impact
High effect
Typical dose:500–2000 mg

Curcumin has strong evidence for supporting long-term brain health through its potent anti-inflammatory mechanisms.

Focuses on
MemoryFocusBrain Protection
Most relevant for
Older adults seeking to support memory and focus through long-term use of highly bioavailable formulations.

Potential benefits

  • Working memory and attention.Specific high-absorption formulations have demonstrated improvements in working memory, attention span, and focus in non-demented older adults.
  • Executive function support.Clinical reviews suggest curcumin may help maintain mental flexibility and executive control as part of a healthy aging regimen.
  • Neuroprotective markers.Unconfirmed. While some studies show reduced brain markers associated with cognitive aging, it is not yet proven that these changes directly prevent dementia or cognitive decline.

Limitations

  • Inconsistent clinical results.Research findings are mixed; several trials in healthy adults and those with Alzheimer's disease found no significant impact on overall cognitive performance.
  • Bioavailability constraints.Standard curcumin is poorly absorbed by the body, and benefits seen in research often rely on specific, optimized delivery systems.
  • Extended duration required.Evidence suggests that cognitive benefits may only become significant after at least 24 weeks of consistent daily supplementation.
Things to consider

Curcumin is frequently associated with gastrointestinal side effects such as nausea or diarrhea, which can lead to discontinued use.

Study evidence

14 studies

Curcumin may improve some aspects of memory and thinking, but results are inconsistent across formulations and populations. The supplied research does not establish a dependable overall cognitive benefit or dementia prevention, and digestive side effects occur more often than with placebo.

View goal
Everyday Health
Impact
High effect
Typical dose:500–1500 mg

Curcumin targets multiple inflammatory pathways in the body. However, standard curcumin is poorly absorbed. For effective results, it must be consumed in a form with enhanced bioavailability, such as one combined with piperine (black pepper extract) or formulated with phytosomes.

Focuses on
Inflammation
Most relevant for
Individuals seeking to manage markers of inflammation and support metabolic health through enhanced-absorption supplements.

Potential benefits

  • Metabolic and Inflammatory Support.Meta-analyses indicate high-certainty evidence that curcumin can improve fasting blood sugar and C-reactive protein (CRP) levels, key markers of metabolic health and systemic inflammation.
  • Joint Comfort and Function.Clinical trials show that curcuminoids can significantly reduce pain and improve quality of life scores in individuals experiencing joint discomfort, though they may be less effective than standard NSAIDs.
  • Exercise Recovery Support.Specific bioavailable turmeric formulations have been shown to accelerate recovery from muscle soreness and attenuate the loss of muscular function following unaccustomed intense exercise.

Limitations

  • Unproven General Health Benefit.While curcumin improves specific laboratory markers, there is no established evidence that these changes translate to disease prevention or improved overall health in otherwise healthy populations.
  • Variable Results by Condition.Benefits observed in some inflammatory conditions, such as ulcerative colitis, do not extend to others; research in Crohn's disease showed no benefit and a potential for increased severe recurrence.
  • Absorption Dependency.Standard curcumin is poorly absorbed by the body; most documented benefits rely on specific high-bioavailability formulations, such as nano-curcumin or combinations with piperine.
Things to consider

Curcumin may cause mild gastrointestinal side effects like nausea or reflux. It should be used with caution in individuals with specific inflammatory bowel conditions like Crohn's disease due to reports of worsening severe symptoms.

Study evidence

64 studies

Curcumin may improve selected metabolic markers, inflammatory measures, and symptoms in some health conditions. These benefits vary by outcome and formulation, and the available research does not establish a broad general-health benefit for everyone; some clinical settings show no benefit or unfavorable findings.

View goal
Gut Health
Impact
High effect
Typical dose:500–1500 mg

Curcumin, the active compound in turmeric, is a potent inhibitor of NF-kB, a key driver of inflammation. While standard curcumin has poor bioavailability, formulations combined with piperine or other absorption enhancers are highly effective for reducing gut inflammation.

Focuses on
Gut Inflammation
Most relevant for
Adults seeking supplemental support for irritable bowel symptoms or adjunctive care for inflammatory bowel conditions.

Potential benefits

  • Ulcerative Colitis Support.When added to standard medical care, curcumin may help improve clinical remission rates and reduce symptom severity in patients with ulcerative colitis.
  • IBS Symptom Management.Systematic reviews suggest curcumin can help lower the severity of abdominal pain and improve quality of life for those with irritable bowel syndrome.
  • Digestive Complaint Relief.Clinical trials in adults with general digestive issues show significant reductions in overall gastrointestinal symptom scores after several weeks of use.

Limitations

  • Limited Microbiome Impact.Despite symptom improvement, research has not consistently demonstrated that curcumin significantly changes gut bacterial diversity or resolves bacterial overgrowth.
  • Ineffective for Infections.Curcumin has not been shown to be effective as a standalone treatment for H. pylori or for preventing diarrhea caused by chemotherapy.
  • Inconsistent Endoscopic Results.In inflammatory conditions, curcumin may improve clinical symptoms without showing statistically significant healing of the intestinal lining on endoscopic exams.
Things to consider

Standard curcumin formulations have poor bioavailability; products utilizing enhancers like piperine or nano-formulations are typically required to reach effective levels in the body.

Study evidence

31 studies

Curcumin may relieve some digestive symptoms and improve ulcerative colitis outcomes when added to standard treatment. Benefits vary by condition and formulation, and the evidence does not establish broad improvements in the gut microbiome or reliable treatment of digestive infections.

View goal
Heart Health
Impact
High effect
Typical dose:500–1500 mg

Curcumin's primary benefit comes from its ability to down-regulate inflammatory markers like NF-kB and COX-2. It also improves endothelial function, comparable to exercise in some studies. Its effectiveness is highly dependent on using a high-bioavailability form (e.g., with piperine).

Focuses on
Blood PressureCholesterolArtery Health
Most relevant for
Adults with metabolic syndrome or type 2 diabetes seeking to manage cardiovascular risk markers alongside conventional care.

Potential benefits

  • Lipid Profile Support.Meta-analyses suggest curcumin may help lower total cholesterol, LDL, and triglycerides while slightly increasing HDL, particularly in individuals with metabolic disorders.
  • Vascular Health.Supplementation may improve endothelial function and reduce arterial stiffness, as indicated by improvements in flow-mediated dilation and pulse wave velocity in several clinical trials.
  • Modest Blood Pressure Support.In specific populations like those with prediabetes or when taken for over 12 weeks, curcumin may help modestly reduce systolic or diastolic blood pressure.

Limitations

  • Inconsistent Results.Multiple high-quality trials and meta-analyses found no significant overall effect on blood pressure or lipid profiles in general or healthy populations.
  • Ineffective in Certain Conditions.Research indicates curcumin does not improve vascular function in patients with chronic kidney disease or autosomal dominant polycystic kidney disease.
  • Bioavailability Dependent.Standard curcumin is poorly absorbed; many heart-related benefits observed in studies relied on high-bioavailability formulas or the addition of piperine.
Things to consider

Clinical benefits for preventing heart attacks or strokes are not established. Reported side effects include nausea, headache, and yellow stool. Consult a provider if you have underlying cardiovascular or kidney conditions.

Study evidence

70 studies

Curcumin may modestly improve some cholesterol and blood-vessel measures, particularly in people with metabolic disorders. Findings for blood pressure and other heart-risk markers are inconsistent, and the supplied evidence does not establish that supplementation prevents heart attacks or other cardiovascular events.

View goal
Inflammation
Impact
High effect
Typical dose:500–1500 mg

Curcumin, the active component in turmeric, is one of the most well-researched anti-inflammatory botanicals. It effectively reduces markers of inflammation like CRP and blocks enzymes such as COX-2. For clinical efficacy, it must be taken in a form with enhanced bioavailability, such as combined with piperine or formulated as a phytosome.

Focuses on
Inflammation LevelsJoint Inflammation
Most relevant for
Individuals seeking to manage elevated systemic inflammation or joint-related inflammatory markers as an adjunct to standard care.

Potential benefits

  • Reduction of CRP Levels.Multiple meta-analyses indicate curcumin can significantly lower C-reactive protein (CRP) and high-sensitivity CRP, though the effect is most pronounced in settings of existing systemic inflammation.
  • Joint Disease Support.Research in rheumatoid and osteoarthritis suggests curcumin may improve clinical disease activity scores (DAS-28) and reduce the erythrocyte sedimentation rate (ESR) in affected patients.
  • Cytokine Modulation.Evidence suggests a capacity to lower circulating pro-inflammatory cytokines like Interleukin-6 (IL-6) and TNF-alpha, particularly in participants with metabolic syndrome or elevated baseline levels.

Limitations

  • Variable Clinical Efficacy.Several high-quality reviews found no significant reduction in inflammatory markers across diverse conditions like cardiovascular disease, lupus, or advanced kidney disease.
  • Bioavailability Dependency.Anti-inflammatory outcomes are often inconsistent and may rely on specialized formulations, such as nano-curcumin or piperine, to ensure adequate systemic absorption.
  • High Study Heterogeneity.Research findings are characterized by significant differences in doses and participant populations, making it difficult to predict outcomes for the general healthy population.
Things to consider

Consistent supplementation for at least 4 to 12 weeks is typically required to observe changes in inflammatory markers.

Study evidence

68 studies

Curcumin can reduce some markers of inflammation, particularly in people with inflammatory or metabolic conditions, but results vary substantially. Evidence for symptom improvement is condition-specific, and changes in blood markers do not establish a broad or lasting health benefit.

View goal
Joint Health
Impact
High effect
Typical dose:500–1500 mg

Curcumin, the active component in Turmeric, effectively targets pathways like NF-kB and COX-2. Its efficacy is comparable to some NSAIDs for osteoarthritis pain, but standard forms have poor bioavailability; it must be combined with an absorption enhancer like piperine or formulated as a phytosome.

Focuses on
Joint Inflammation
Most relevant for
Adults with knee osteoarthritis seeking relief from joint pain and stiffness.

Potential benefits

  • Alleviates Osteoarthritis Pain.Extensive meta-analyses indicate that curcumin significantly reduces joint pain scores, with efficacy often matching standard anti-inflammatory medications like ibuprofen and diclofenac.
  • Enhances Physical Mobility.Regular use is associated with improved physical function scores and reduced stiffness, particularly in individuals with mild-to-moderate knee osteoarthritis.
  • Better Tolerability Profile.Compared to traditional anti-inflammatory drugs, curcumin formulations are frequently associated with fewer gastrointestinal side effects while providing similar symptom relief.

Limitations

  • Unproven for Healthy Joints.Benefits are primarily proven for those with existing joint conditions; evidence does not support using curcumin to maintain normal joint function or prevent disease in healthy individuals.
  • Structural Impact Uncertainty.Evidence that curcumin preserves cartilage or protects joint structure long-term is inconsistent, as imaging studies often fail to show significant structural changes.
  • Variable Formulation Efficacy.Clinical results vary significantly between different formulations, and short-term use (less than one week) often fails to outperform a placebo.
Things to consider

Standard curcumin has poor absorption and usually requires enhancers like piperine or specialized delivery systems to be effective. Optimal results in clinical trials often require at least 4 to 12 weeks of consistent use.

Study evidence

62 studies

Curcumin can help reduce pain and improve function in knee osteoarthritis, although results differ between studies and formulations. Evidence is stronger for symptom relief than for preserving cartilage, preventing arthritis or maintaining normal joint function in people without joint disease.

View goal
Showing 6 of 16 goals

Studies

Research connections will load here.
Sources

Up to five highest-ranked published examples per goal. Study counts and charts include all published studies for the connection.

  1. Curcumin-Rich Curry Consumption Is Associated with Lower Risk of Cognitive Decline and Incidence of Mild Cognitive Impairment or Dementia: An Asian Population-Based Study.
    Lu Y; Lee TS; Lim WS; Yap P; Cheong CY; Rawtaer I; Liew TM; Gwee X; Gao Q; Yap KB; Ng TP · Nutrients · 2025
    Cohort study2,920 participantsBrain HealthCognitive Support
  2. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.
    Nunes YC; Mendes NM; Pereira de Lima E; Chehadi AC; Lamas CB; Haber JFS; Dos Santos Bueno M; Araújo AC; Catharin VCS; Detregiachi CRP; Laurindo LF; Tanaka M; Barbalho SM; Marin MJS · Nutrients · 2024
    Systematic review15 studies pooledCognitive SupportLongevity
  3. The effect of curcumin supplementation on cognitive function: an updated systematic review and meta-analysis.
    Wang W; Zhao R; Liu B; Li K · Frontiers in nutrition · 2025
    Meta-analysis501 participants9 studies pooledCognitive Support
  4. Curcumin and Cognitive Health: Insights from Randomized Controlled Trials.
    Sivamaruthi BS; Chaiyasut C; Kesika P · Current pharmaceutical design · 2026
    Narrative reviewCognitive Support
  5. Botanicals and phytochemicals active on cognitive decline: The clinical evidence.
    Cicero AFG; Fogacci F; Banach M · Pharmacological research · 2019
    Systematic reviewCognitive Support
  6. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis.
    Sadeghi N; Mansoori A; Shayesteh A; Hashemi SJ · Phytotherapy research : PTR · 2020
    Randomized trial70 participantsEveryday Health
  7. The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial.
    Parohan M; Sarraf P; Javanbakht MH; Foroushani AR; Ranji-Burachaloo S; Djalali M · Nutritional neuroscience · 2021
    Randomized trial100 participantsEveryday Health
  8. Efficacy and Safety of a Novel Low-Dose Water-Dispersible Turmeric Extract in the Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Thanawala S; Shah R; Alluri KV; Bhupathiraju K; Prasad N; Agarwal Y · Journal of pain research · 2025
    Randomized trial139 participantsEveryday Health
  9. Effectiveness of curcuminoids in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized clinical trials.
    Onakpoya IJ; Spencer EA; Perera R; Heneghan CJ · International journal of rheumatic diseases · 2018
    Meta-analysis797 participants7 studies pooledEveryday Health
  10. Effectiveness and safety of turmeric for the treatment of COVID-19: An updated systematic review and meta-analysis of randomized controlled trials.
    Sawangjit R; Sadoyu S; Manosanthipaibul S; Teerawattanapong N; Puttarak P; Wanaratna K; Charoensup R; Hiransai P; Meetam T; Chaiyakunapruk N · Complementary therapies in medicine · 2025
    Meta-analysis1,407 participants23 studies pooledEveryday Health
  11. Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management.
    Nurcahyanti ADR; Cokro F; Wulanjati MP; Mahmoud MF; Wink M; Sobeh M · Frontiers in nutrition · 2022
    Meta-analysisGut Health
  12. [Curcumin in children with autism spectrum disorder: systemic inflammation, sensory regulation, and gut-brain interaction disorders. A randomized, double-blind, placebo-controlled clinical trial (CURATEA)].
    Vergara Serpa JJ; Sumalla Cano S · Nutricion hospitalaria · 2026
    Randomized trial60 participantsBrain HealthGut Health
  13. Curcumin supplementation during high-altitude exposure modulates body composition and its relationship with gut microbiota: a randomized controlled trial.
    Hu J; Fan D; Xiao C; Kang C; Shi J; Li Y; Liu J; Shen L; Lin N · Nutrition journal · 2026
    Randomized trial102 participantsGut Health
  14. Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies.
    Abalo R; Gallego-Barceló P; Gabbia D · International journal of molecular sciences · 2025
    Randomized trialGut Health
  15. Turmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence.
    Jafarzadeh E; Shoeibi S; Bahramvand Y; Nasrollahi E; Maghsoudi AS; Yazdi F; KarkonShayan S; Hassani S · Iranian journal of public health · 2022
    Systematic review9 studies pooledGut Health
  16. The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Alidadi M; Sahebkar A; Eslami S; Vakilian F; Jarahi L; Alinezhad-Namaghi M; Arabi SM; Vakili S; Tohidinezhad F; Nikooiyan Y; Norouzy A · Advances in experimental medicine and biology · 2021
    Randomized trial66 participantsHeart Health
  17. The Effects of Nano-curcumin on Metabolic Status in Patients With Diabetes on Hemodialysis, a Randomized, Double Blind, Placebo-controlled Trial.
    Shafabakhsh R; Asemi Z; Reiner Z; Soleimani A; Aghadavod E; Bahmani F · Iranian journal of kidney diseases · 2021
    Randomized trial60 participantsHeart Health
  18. Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk.
    El-Rakabawy OM; Elkholy AA; Mahfouz AA; Abdelsalam MM; El Wakeel LM · Scientific reports · 2025
    Randomized trial72 participantsHeart Health
  19. Curcumin Nanomicelle Improves Lipid Profile, Stress Oxidative Factors and Inflammatory Markers in Patients Undergoing Coronary Elective Angioplasty; A Randomized Clinical Trial.
    Helli B; Gerami H; Kavianpour M; Heybar H; Hosseini SK; Haghighian HK · Endocrine, metabolic & immune disorders drug targets · 2022
    Randomized trial90 participantsCardiovascular SupportHeart Health
  20. The Effect of Curcumin on Reducing Atherogenic Risks in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    Yaikwawong M; Jansarikit L; Jirawatnotai S; Chuengsamarn S · Nutrients · 2024
    Randomized trial227 participantsHeart Health
  21. Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis.
    Zhang F; Niu B · Medicine · 2025
    Meta-analysis7 studies pooledInflammation
  22. Effect of curcumin on C-reactive protein as a biomarker of systemic inflammation: An updated meta-analysis of randomized controlled trials.
    Gorabi AM; Abbasifard M; Imani D; Aslani S; Razi B; Alizadeh S; Bagheri-Hosseinabadi Z; Sathyapalan T; Sahebkar A · Phytotherapy research : PTR · 2022
    Meta-analysis32 studies pooledInflammation
  23. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials.
    Derosa G; Maffioli P; Simental-Mendía LE; Bo S; Sahebkar A · Pharmacological research · 2018
    Meta-analysis9 studies pooledInflammation
  24. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ · Nutrition & metabolism · 2024
    Randomized trial84 participantsCardiovascular SupportInflammationLiver & Detox
  25. Is Curcumin Intake Really Effective for Chronic Inflammatory Metabolic Disease? A Review of Meta-Analyses of Randomized Controlled Trials.
    Lee YM; Kim Y · Nutrients · 2024
    Systematic review54 studies pooledInflammation
  26. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.
    Zhao J; Liang G; Zhou G; Hong K; Yang W; Liu J; Zeng L · Journal of ethnopharmacology · 2024
    Meta-analysis2,175 participants23 studies pooledJoint Health
  27. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
    Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H · Frontiers in immunology · 2022
    Meta-analysis2,396 participants29 studies pooledJoint Health
  28. The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.
    Bideshki MV; Jourabchi-Ghadim N; Radkhah N; Behzadi M; Asemani S; Jamilian P; Zarezadeh M · Phytotherapy research : PTR · 2024
    Meta-analysis11 studies pooledJoint Health
  29. The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis.
    Hsiao AF; Lien YC; Tzeng IS; Liu CT; Chou SH; Horng YS · Complementary therapies in medicine · 2021
    Meta-analysis1,258 participants11 studies pooledJoint Health
  30. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis.
    Zeng L; Yu G; Hao W; Yang K; Chen H · Bioscience reports · 2022
    Meta-analysis1,621 participants15 studies pooledJoint Health
  31. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Vajdi M; Hassanizadeh S; Hassanizadeh R; Bagherniya M · Nutrition reviews · 2024
    Meta-analysis905 participants15 studies pooledLiver & Detox
  32. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Ebrahimzadeh A; Fooladshekan S; Mohseni S; Mohtashamian A; Babajafari S; Sohrabi Z · Food science & nutrition · 2025
    Meta-analysis14 studies pooledLiver & Detox
  33. Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Yaikwawong M; Kamdee K; Chuengsamarn S · International journal of molecular sciences · 2025
    Randomized trial227 participantsLiver & Detox
  34. A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study.
    T Krishnareddy N; Thomas JV; Nair SS; N Mulakal J; Maliakel BP; Krishnakumar IM · BioMed research international · 2019
    Randomized trial48 participantsLiver & Detox
  35. Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study.
    Cox KHM; White DJ; Pipingas A; Poorun K; Scholey A · Nutrients · 2021
    Randomized trial80 participantsLongevity
  36. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women.
    Akazawa N; Choi Y; Miyaki A; Tanabe Y; Sugawara J; Ajisaka R; Maeda S · Nutrition research (New York, N.Y.) · 2013
    Clinical trial32 participantsLongevity
  37. A novel phospholipid delivery system of curcumin (Meriva®) preserves muscular mass in healthy aging subjects.
    Franceschi F; Feregalli B; Togni S; Cornelli U; Giacomelli L; Eggenhoffner R; Belcaro G · European review for medical and pharmacological sciences · 2016
    Non-randomized trial86 participantsLongevity
  38. Curcumin and arterial function in health and disease: impact on oxidative stress and inflammation.
    Fleenor BS; Carlini NA; Campbell MS · Current opinion in clinical nutrition and metabolic care · 2020
    Narrative reviewLongevity
  39. Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.
    Yaikwawong M; Jansarikit L; Jirawatnotai S; Chuengsamarn S · Nutrition journal · 2024
    Randomized trial272 participantsMetabolism Support
  40. The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Mokhtari M; Razzaghi R; Momen-Heravi M · Phytotherapy research : PTR · 2021
    Randomized trial60 participantsMetabolism Support
  41. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z · Clinical nutrition ESPEN · 2021
    Randomized trial60 participantsMetabolism Support
  42. Effects of metformin and curcumin in women with polycystic ovary syndrome: A factorial clinical trial.
    Feghhi F; Ghaznavi H; Sheervalilou R; Razavi M; Sepidarkish M · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
    Randomized trial200 participantsMetabolism Support
  43. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial.
    Cicero AFG; Sahebkar A; Fogacci F; Bove M; Giovannini M; Borghi C · European journal of nutrition · 2021
    Randomized trial80 participantsMetabolism Support
  44. Effect and Safety of Phytosomal Curcumin Supplementation on Migraine Patients: A Randomized, Double-Blind and Placebo-Controlled Trial.
    Shojaei M; Khorvash F; Sahebkar A; Sathyapalan T; Bagherniya M · Chinese journal of integrative medicine · 2025
    Randomized trial70 participantsStress Relief
  45. Curcumin for depression: a meta-analysis.
    Fusar-Poli L; Vozza L; Gabbiadini A; Vanella A; Concas I; Tinacci S; Petralia A; Signorelli MS; Aguglia E · Critical reviews in food science and nutrition · 2020
    Meta-analysis531 participants9 studies pooledStress Relief
  46. Effect of curcumin supplementation on symptoms of anxiety: A systematic review and meta-analysis of randomized controlled trials.
    Fathi S; Agharloo S; Falahatzadeh M; Bahraminavid S; Homayooni A; Faghfouri AH; Shafiei D; Shafagh SG · Clinical nutrition ESPEN · 2024
    Meta-analysis567 participants8 studies pooledMood SupportStress Relief
  47. Efficacy of a curcumin extract (Curcugenâ„¢) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study.
    Lopresti AL; Smith SJ; Rea A; Michel S · BMC complementary medicine and therapies · 2021
    Randomized trial79 participantsStress Relief
  48. The effect of curcumin on postpartum depression and anxiety in primiparous women: a double-blind randomized placebo-controlled clinical trial.
    Hamlbar EP; Mirghafourvand M; Shaseb E; Kamalifard M · BMC complementary medicine and therapies · 2025
    Randomized trial96 participantsStress Relief
  49. Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: a systematic review and dose-response meta-analysis of randomized controlled trials.
    Sarraf P; Parohan M; Javanbakht MH; Ranji-Burachaloo S; Djalali M · Nutrition research (New York, N.Y.) · 2020
    Meta-analysis139 participants4 studies pooledBrain Health
  50. Curcumin-Rich Curry Consumption and Neurocognitive Function from 4.5-Year Follow-Up of Community-Dwelling Older Adults (Singapore Longitudinal Ageing Study).
    Ng TP; Nyunt MSZ; Gao Q; Gwee X; Chua DQL; Yap KB · Nutrients · 2022
    Cohort study2,734 participantsBrain Health
  51. The effects of oral administration of curcumin-galactomannan complex on brain waves are consistent with brain penetration: a randomized, double-blinded, placebo-controlled pilot study.
    Khanna A; Das S S; Kannan R; Swick AG; Matthewman C; Maliakel B; Ittiyavirah SP; Krishnakumar IM · Nutritional neuroscience · 2022
    Randomized trial18 participantsBrain Health
  52. Effects of Curcumin on Bone Loss and Biochemical Markers of Bone Turnover in Patients with Spinal Cord Injury.
    Hatefi M; Ahmadi MRH; Rahmani A; Dastjerdi MM; Asadollahi K · World neurosurgery · 2018
    Non-randomized trial100 participantsBone Health
  53. The Effect of Selected Herbal Medicines on Bone Turnover Markers: A Systematic Review and Meta-Analysis.
    Kheiridoost-Langaroodi H; Shakouri SK; Amirpour M; Iranshahi AM; Farshbaf-Khalili A · Journal of family & reproductive health · 2022
    Meta-analysis968 participants16 studies pooledBone Health
  54. Efficacy of nanomicelle curcumin, Nigella sativa oil, and their combination on bone turnover markers and their safety in postmenopausal women with primary osteoporosis and osteopenia: A triple-blind randomized controlled trial.
    Kheiridoost H; Shakouri SK; Shojaei-Zarghani S; Dolatkhah N; Farshbaf-Khalili A · Food science & nutrition · 2023
    Randomized trial120 participantsBone Health
  55. The Effect of Curcumin on Postmenopausal Symptoms: A Systematic Review Based on Randomized Controlled Trials.
    Akyakar B; Şahin İN; Ağagündüz D; Szép D; Budán F · International journal of molecular sciences · 2025
    Systematic review12 studies pooledBone Health
  56. Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study.
    Riva A; Togni S; Giacomelli L; Franceschi F; Eggenhoffner R; Feragalli B; Belcaro G; Cacchio M; Shu H; Dugall M · European review for medical and pharmacological sciences · 2017
    Non-randomized trial57 participantsBone Health
  57. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials.
    Qin S; Huang L; Gong J; Shen S; Huang J; Ren H; Hu H · Nutrition journal · 2018
    Meta-analysis649 participants7 studies pooledCardiovascular Support
  58. Effects of nanocurcumin supplementation on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Wilar G; Suhandi C; Fukunaga K; Shigeno M; Kawahata I; Abdulah R; Sasaki T · Pharmacological research · 2025
    Meta-analysis1,394 participants20 studies pooledCardiovascular Support
  59. The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Metaanalysis of Randomized Controlled Trials.
    Tabrizi R; Vakili S; Lankarani KB; Akbari M; Mirhosseini N; Ghayour-Mobarhan M; Ferns G; Karamali F; Karamali M; Taghizadeh M; Kouchaki E; Asemi Z · Current pharmaceutical design · 2019
    Meta-analysis1,890 participants26 studies pooledCardiovascular Support
  60. The effect of curcumin supplementation on delayed-onset muscle soreness, inflammation, muscle strength, and joint flexibility: A systematic review and dose-response meta-analysis of randomized controlled trials.
    Beba M; Mohammadi H; Clark CCT; Djafarian K · Phytotherapy research : PTR · 2022
    Meta-analysis10 studies pooledFitness
  61. The Effects of Curcumin Supplementation on Muscle Damage, Oxidative Stress, and Inflammatory Markers in Healthy Females with Moderate Physical Activity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Salehi M; Mashhadi NS; Esfahani PS; Feizi A; Hadi A; Askari G · International journal of preventive medicine · 2023
    Randomized trial80 participantsFitness
  62. Modulation of Exercise-Induced Muscle Damage, Inflammation, and Oxidative Markers by Curcumin Supplementation in a Physically Active Population: A Systematic Review.
    Fernández-Lázaro D; Mielgo-Ayuso J; Seco Calvo J; Córdova Martínez A; Caballero García A; Fernandez-Lazaro CI · Nutrients · 2020
    Systematic review11 studies pooledFitness
  63. Effects of Turmeric Concentrate on Cardiovascular Risk Factors and Exercise-Induced Oxidative Stress in Healthy Volunteers; an Exploratory Study.
    Hajleh MNA; Al-Dujaili EAS · Advanced pharmaceutical bulletin · 2023
    Randomized trial22 participantsFitness
  64. Effects of curcumin supplementation on sport and physical exercise: a systematic review.
    Suhett LG; de Miranda Monteiro Santos R; Silveira BKS; Leal ACG; de Brito ADM; de Novaes JF; Lucia CMD · Critical reviews in food science and nutrition · 2021
    Systematic review11 studies pooledFitness
  65. Effect of curcumin on nasal symptoms and airflow in patients with perennial allergic rhinitis.
    Wu S; Xiao D · Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2017
    Randomized trial241 participantsImmunity
  66. Effects of Highly Bioavailable Curcumin Supplementation on Common Cold Symptoms and Immune and Inflammatory Functions in Healthy Japanese Subjects: A Randomized Controlled Study.
    Kuwabara Y; Hirose A; Lee H; Kakinuma T; Baba A; Takara T · Journal of dietary supplements · 2023
    Randomized trial99 participantsImmunity
  67. Effects of curcumin-piperine supplementation on systemic immunity in young women with premenstrual syndrome and dysmenorrhea: A randomized clinical trial.
    Bahrami A; Mohammadifard M; Rajabi Z; Motahari-Nasab M; Ferns GA · European journal of obstetrics, gynecology, and reproductive biology · 2022
    Randomized trial80 participantsImmunity
  68. The roles of curcumin in regulating the tumor immunosuppressive microenvironment.
    Wang Y; Lu J; Jiang B; Guo J · Oncology letters · 2020
    Narrative reviewImmunity
  69. Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature.
    Nebrisi EE · International journal of molecular sciences · 2021
    Narrative reviewImmunity
  70. Clinical Use of Curcumin in Depression: A Meta-Analysis.
    Ng QX; Koh SSH; Chan HW; Ho CYX · Journal of the American Medical Directors Association · 2018
    Meta-analysis377 participants6 studies pooledMood Support
  71. Efficacy of curcumin in depression: A grade-assessed systematic review and meta-analysis of randomized controlled trials.
    Musazadeh V; Faghfouri AH; Falahatzadeh M; Mahmoudinezhad M; Alizadeh M; Shidfar F · Annals of general psychiatry · 2026
    Meta-analysis19 studies pooledMood Support
  72. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.
    Lopresti AL; Maes M; Maker GL; Hood SD; Drummond PD · Journal of affective disorders · 2015
    Randomized trial56 participantsMood Support
  73. Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study.
    Kanchanatawan B; Tangwongchai S; Sughondhabhirom A; Suppapitiporn S; Hemrunrojn S; Carvalho AF; Maes M · Neurotoxicity research · 2018
    Randomized trial65 participantsMood Support